185 related articles for article (PubMed ID: 7261282)
1. Results of long-term vasodilator therapy in patients with refractory congestive heart failure.
Walsh WF; Greenberg BH
Circulation; 1981 Sep; 64(3):499-505. PubMed ID: 7261282
[TBL] [Abstract][Full Text] [Related]
2. Long-term vasodilator therapy for heart failure: clinical response and its relationship to hemodynamic measurements.
Massie B; Ports T; Chatterjee K; Parmley W; Ostland J; O'Young J; Haughom F
Circulation; 1981 Feb; 63(2):269-78. PubMed ID: 6778625
[TBL] [Abstract][Full Text] [Related]
3. Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study.
Cohn JN; Archibald DG; Ziesche S; Franciosa JA; Harston WE; Tristani FE; Dunkman WB; Jacobs W; Francis GS; Flohr KH
N Engl J Med; 1986 Jun; 314(24):1547-52. PubMed ID: 3520315
[TBL] [Abstract][Full Text] [Related]
4. Sustained hemodynamic efficacy of therapy tailored to reduce filling pressures in survivors with advanced heart failure.
Steimle AE; Stevenson LW; Chelimsky-Fallick C; Fonarow GC; Hamilton MA; Moriguchi JD; Kartashov A; Tillisch JH
Circulation; 1997 Aug; 96(4):1165-72. PubMed ID: 9286945
[TBL] [Abstract][Full Text] [Related]
5. Postural hypotension and tachycardia during hydralazine--isosorbide dinitrate therapy for chronic heart failure.
Massie B; Kramer B; Haughom F
Circulation; 1981 Mar; 63(3):658-64. PubMed ID: 6780233
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the effects of dopamine, hydralazine, and isosorbide dinitrate on myocardial hemodynamics in patients with refractory heart failure.
Biddle TL; Moses HW
J Clin Pharmacol; 1981; 21(8-9):343-50. PubMed ID: 7276228
[TBL] [Abstract][Full Text] [Related]
7. Mild systolic dysfunction in heart failure (left ventricular ejection fraction >35%): baseline characteristics, prognosis and response to therapy in the Vasodilator in Heart Failure Trials (V-HeFT).
Carson P; Johnson G; Fletcher R; Cohn J
J Am Coll Cardiol; 1996 Mar; 27(3):642-9. PubMed ID: 8606276
[TBL] [Abstract][Full Text] [Related]
8. Vasodilator therapy for chronic left ventricular failure.
Kovick RB; Tillisch JH; Berens SC; Bramowitz AD; Shine KI
Circulation; 1976 Feb; 53(2):322-8. PubMed ID: 812614
[TBL] [Abstract][Full Text] [Related]
9. Hemodynamic effects of vasodilators and long-term response in heart failure.
Franciosa JA; Dunkman WB; Leddy CL
J Am Coll Cardiol; 1984 Jun; 3(6):1521-30. PubMed ID: 6325522
[TBL] [Abstract][Full Text] [Related]
10. Hemodynamic advantage of combined administration of hydralazine orally and nitrates nonparenterally in the vasodilator therapy of chronic heart failure.
Massie B; Chatterjee K; Werner J; Greenberg B; Hart R; Parmley WW
Am J Cardiol; 1977 Nov; 40(5):794-801. PubMed ID: 411364
[TBL] [Abstract][Full Text] [Related]
11. Vasodilator therapy in refractory congestive heart failure: a comparative analysis of hemodynamic and noninvasive studies.
Haq A; Rakowski H; Baigrie R; McLaughlin P; Burns R; Tihal H; Hilton D; Feiglin D
Am J Cardiol; 1982 Feb; 49(2):439-44. PubMed ID: 6800252
[TBL] [Abstract][Full Text] [Related]
12. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure.
Cohn JN; Johnson G; Ziesche S; Cobb F; Francis G; Tristani F; Smith R; Dunkman WB; Loeb H; Wong M
N Engl J Med; 1991 Aug; 325(5):303-10. PubMed ID: 2057035
[TBL] [Abstract][Full Text] [Related]
13. Hemodynamic assessment of oral peripheral vasodilator therapy in chronic congestive heart failure: prolonged effectiveness of isosorbide dinitrate.
Williams DO; Bommer WJ; Miller RR; Amsterdam EA; Mason DT
Am J Cardiol; 1977 Jan; 39(1):84-90. PubMed ID: 318795
[TBL] [Abstract][Full Text] [Related]
14. Isosorbide dinitrate for the relief of severe heart failure after myocardial infarction.
Mantle JA; Russell RO; Moraski RE; Rackley CE
Am J Cardiol; 1976 Feb; 37(2):263-8. PubMed ID: 1108634
[TBL] [Abstract][Full Text] [Related]
15. Ambulatory long-term vasodilator therapy for chronic refractory heart failure: hemodynamic evaluation and clinical response.
Saito S; Ichikawa M; Ozawa Y; Yumikura S; Nagasawa M; Hibiya K; Tamura Y; Tomobe K; Hatano M
Jpn Circ J; 1984 Apr; 48(4):350-6. PubMed ID: 6425526
[TBL] [Abstract][Full Text] [Related]
16. Prevention of tolerance to hemodynamic effects of nitrates with concomitant use of hydralazine in patients with chronic heart failure.
Gogia H; Mehra A; Parikh S; Raman M; Ajit-Uppal J; Johnson JV; Elkayam U
J Am Coll Cardiol; 1995 Dec; 26(7):1575-80. PubMed ID: 7594088
[TBL] [Abstract][Full Text] [Related]
17. Plasma norepinephrine, plasma renin activity, and congestive heart failure. Relations to survival and the effects of therapy in V-HeFT II. The V-HeFT VA Cooperative Studies Group.
Francis GS; Cohn JN; Johnson G; Rector TS; Goldman S; Simon A
Circulation; 1993 Jun; 87(6 Suppl):VI40-8. PubMed ID: 8500238
[TBL] [Abstract][Full Text] [Related]
18. Regression of myocardial cellular hypertrophy with vasodilator therapy in chronic congestive heart failure associated with idiopathic dilated cardiomyopathy.
Unverferth DV; Mehegan JP; Magorien RD; Unverferth BJ; Leier CV
Am J Cardiol; 1983 May; 51(8):1392-8. PubMed ID: 6682617
[TBL] [Abstract][Full Text] [Related]
19. Vasodilators in heart failure secondary to coronary artery disease.
Parmley WW; Rouleau JL; Chatterjee K
Am Heart J; 1982 Apr; 103(4 Pt 2):625-32. PubMed ID: 7064804
[TBL] [Abstract][Full Text] [Related]
20. Hemodynamic comparison of primary venous or arteriolar dilatation and the subsequent effect of furosemide in left ventricular failure after acute myocardial infarction.
Nelson GI; Silke B; Forsyth DR; Verma SP; Hussain M; Taylor SH
Am J Cardiol; 1983 Nov; 52(8):1036-40. PubMed ID: 6637819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]